RedHill Biopharma annual operating margin
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
RedHill Biopharma Operating Margin Growth & History (RDHL)
RedHill Biopharma's operating margin was −2,765.38% for fiscal 2025.
View full RedHill Biopharma company overviewRedHill Biopharma annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −2,765.38% | −2583.70 pp |
| 2024 | 2024-12-31 | −181.69% | −375.13 pp |
| 2023 | 2023-12-31 | 193.45% | +262.77 pp |
| 2022 | 2022-12-31 | −69.33% | +25.28 pp |
| 2021 | 2021-12-31 | −94.61% | +4.34 pp |
| 2020 | 2020-12-31 | −98.95% | +587.76 pp |
| 2019 | 2019-12-31 | −686.71% | −216.24 pp |
| 2018 | 2018-12-31 | −470.47% | +826.56 pp |
| 2017 | 2017-12-31 | −1,297.03% | +28943.56 pp |
| 2016 | 2016-12-31 | −30,240.59% | +703159.41 pp |
| 2015 | 2015-12-31 | −733,400.00% | — |
RedHill Biopharma quarterly operating margin
Q2.17
Q2.18
Q2.19
Q2.20
Q2.21
Q2.22
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2022 | 2022-06-30 | −49.92% | +65.81 pp |
| Q2 2021 | 2021-06-30 | −115.74% | −55.93 pp |
| Q2 2020 | 2020-06-30 | −59.81% | +732.26 pp |
| Q2 2019 | 2019-06-30 | −792.07% | −385.39 pp |
| Q2 2018 | 2018-06-30 | −406.68% | +2396.42 pp |
| Q2 2017 | 2017-06-30 | −2,803.11% | — |
RedHill Biopharma operating margin trends
Over the last five fiscal years, RedHill Biopharma's operating margin decreased from −98.95% to −2,765.38%, a change of −2666.43 percentage points. The latest reported quarter, Q2 2022, shows −49.92%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RedHill Biopharma source filings ↗Community posts
RedHill reports wider first-half loss amid commercial-portfolio transition
RedHill Biopharma ($RDHL) reported a first-half net loss of $6.1 million, compared with $4.1 million a year earlier, and no revenue from continuing operations. Operating cash use was $4.6 million, while the half-year cash balance stood at $ ...
